All the updated news related to lecanemab

All the news related to lecanemab updated in real time

Found 13

forlecanemab

Order by:

Breakthrough Alzheimer’s drug could be in UK use in a year but only for minority

(adds detail in final three pars) Patients could be getting breakthrough Alzheimer’s drug in a year, experts have said, but only a small proportion of patients will benefit unless more is done to boost dementia services in the NHS. Experts estimated ...

23 Nov 2022 at 18:56

Local News

'A historic moment' - Research finds new drug slows memory decline in dementia patients

A British dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug made in Japan has been found to reduce memory decline among patients with early-stage disease. Lecanemab was found to slow decline in participants’ ...

28 Sept 2022 at 18:33

‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’

A dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug has been found to reduce memory decline among patients with early-stage disease. Lecanemab was found to slow decline in participants’ memory and thinking. ...

28 Sept 2022 at 14:45

Charity urges Streeting to ‘act’ in wake of Alzheimer’s drug announcements

A charity has written to Health Secretary Wes Streeting, urging him to step in after it was announced that a drug shown to slow the progression of Alzheimer’s disease may not be rolled out on the NHS in England. The Medicines and Healthcare ...

22 Aug 2024 at 10:13

Patient on lecanemab trial says he is able to ‘live a full life’

A man with memory problems has said he has been able to “live a full life” while taking part in a trial of the drug lecanemab, as his symptoms have “plateaued”. It comes after regulators announced the treatment had been approved for use in ...

22 Aug 2024 at 13:18

New Alzheimer’s drug should not be rolled out on NHS, says spending watchdog

The NHS spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the health service, despite the UK medicines regulator saying it is safe and effective for use. The ...

22 Aug 2024 at 12:36

Alzheimer’s drugs ‘will not address dementia risk at scale’, researchers claim

New drugs being developed to tackle Alzheimer’s disease “will not address dementia risk at scale”, researchers have warned. Academics said there is “a lot of hyperbole” around medications such as lecanemab and donanemab which are ...

06 Aug 2024 at 12:00

Clear need to improve NHS screening for new Alzheimer’s drugs – study

There is a “clear and urgent” need to improve NHS screening to work out who may benefit from new Alzheimer’s drugs, according to a study. Experts found that just 14% of people screened in specialist clinics may end up benefiting ...

11 Jun 2024 at 23:30

NHS England sets up team to plan rollout of promising new drugs

NHS England has set up a team that will plan how to roll out promising new drugs even as they wait to be approved by regulators, the chief executive of the health service has said. It comes after new drug donanemab was found to ...

02 Jul 2023 at 13:47

New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment

Experts have hailed the “beginning of the end” in the search for effective Alzheimer’s treatments after a new drug reduced memory decline among patients with early stages of the disease. Lecanemab, which is designed to target ...

30 Nov 2022 at 02:38

Medicines regulator set to give Alzheimer’s drug green light

The UK’s medicines regulator is set to approve a drug that has been shown to slow the progression of Alzheimer’s disease. Lecanemab, developed by pharmaceutical company Eisai, is a targeted antibody treatment that binds to ...

22 Aug 2024 at 08:14

How do the new antibody drugs for Alzheimer’s disease work?

Two new drugs for Alzheimer’s have been rejected for use on the NHS. They slow progression of the disease, but they can have serious side-effects. – What are the medicines? Donanemab and lecanemab are targeted antibody ...

19 Jun 2025 at 00:01

Years
2025

Iconic Media is Ireland's largest independently owned regional newspaper and media group, with an unrivalled audience in print, online and mobile. We have 19 regional newspapers and 21 digital sites.

Iconic Digital Titles

Iconic Print Titles

Letterkenny Live

This publication supports the work of the Press Council of Ireland and Office of the Press Ombudsman, and our staff operate within the Code of Practice of the Press Council. You can obtain a copy of the Code, or contact the Council, at www.presscouncil.ie, Lo-call 1800 208 080 or email: info@presscouncil.ie.